Bruker’s BRKR strong growth reflects its fundamental commitment to innovate high-value solutions and ongoing portfolio ...

M&T Bank Corp lifted its stake in Bruker Co. (NASDAQ:BRKR – Free Report) by 303.1% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 17,870 shares of the medical ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including ...

Stock analysts at Zacks Research upped their Q4 2025 EPS estimates for Bruker in a research report issued to clients and investors on Thursday, March 6th. Zacks Research analyst R. Department now ...

Bruker Corporation (Nasdaq: BRKR) today announces the launch of the new X4 POSEIDON™, a high-performance 3D X-ray microscope (XRM) using micro-Computed Tomography (microCT). This innovative benchtop ...

Bruker Corporation BRKR recently launched the new X4 POSEIDON, a high-performance 3D X-ray microscope (XRM) using ...

Bruker finished 2024 with another quarter of ... consisting of 4.2% organic growth in Scientific Instruments and 1.9% organic growth at BEST, net of eliminations. Acquisitions added 10% revenue ...

(3) Bruker Scientific Instruments (BSI) revenue reflects the sum of the BSI BioSpin, CALID and Nano Segments as presented in our Annual Report on Form 10-K for the year ended December 31 ...

We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts. In this article, we are ...

The London Company, an investment management company, released “The London Company Large Cap Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. U.S.

KONTICH, Belgium - Bruker Corporation (NASDAQ:BRKR), a $7.37 billion scientific instruments manufacturer currently trading near its 52-week low of $48.36, has introduced the X4 POSEIDON ...